PMID: 16507224Mar 2, 2006Paper

How to reduce radiation-related toxicity in patients with cancer of the head and neck

Current Oncology Reports
Adam GardenMark S Chambers

Abstract

Radiation for head and neck cancers is often curative, but high doses are used. Normal tissues, including mucosa, salivary glands, and muscles, are exposed to these high doses, resulting in severe mucositis, xerostomia, and dysphagia. Efforts to minimize toxicity have involved advances in radiation physics and development of pharmacologic agents. Radiation techniques include conformal and intensity-modulated therapy, which minimizes dose to normal tissues while delivering high doses to tumor targets. Drugs used to prevent mucositis have targeted infection, but recently interest has been shown in the use of growth factors. Cholinergic agonists and cytoprotective agents, specifically amifostine, can address xerostomia. Involvement of speech pathologists in evaluation and treatment of patients with dysphagia can minimize swallowing difficulties and identify the tissues most responsible for swallowing. Minimizing radiation dose to these tissues may lower the incidence of radiation-induced dysphagia.

References

Aug 5, 1993·The New England Journal of Medicine·J T JohnsonS C Gallagher
Apr 16, 1998·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·J BüntzelM Glatzel
Apr 20, 1999·Archives of Otolaryngology--head & Neck Surgery·T KotzR V Smith
Oct 3, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D M BrizelR Sauer
Jun 8, 2001·International Journal of Radiation Oncology, Biology, Physics·A EisbruchJ A Ship
Feb 19, 2002·International Journal of Radiation Oncology, Biology, Physics·Dosia AntonadouNicolas Throuvalas
May 15, 2002·International Journal of Radiation Oncology, Biology, Physics·Avraham EisbruchGregory T Wolf
May 14, 2003·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Andy TrottiMarya D Zilberberg
Jul 3, 2003·The Lancet Infectious Diseases·J Peter DonnellyR Paul Symonds
Dec 3, 2003·The New England Journal of Medicine·Arlene A ForastiereJay Cooper
Apr 2, 2004·Nature Reviews. Cancer·Stephen T Sonis
Apr 20, 2004·Seminars in Radiation Oncology·Adam S GardenK Kian Ang
Apr 27, 2004·Cancer·Edward B RubensteinUNKNOWN International Society for Oral Oncology
May 7, 2004·The New England Journal of Medicine·Jay S CooperUNKNOWN Radiation Therapy Oncology Group 9501/Intergroup
May 7, 2004·The New England Journal of Medicine·Jacques BernierUNKNOWN European Organization for Research and Treatment of Cancer Trial 22931
Dec 14, 2004·International Journal of Radiation Oncology, Biology, Physics·Avraham EisbruchAlfons J M Balm
Dec 17, 2004·The New England Journal of Medicine·Ricardo SpielbergerChristos Emmanouilides
Jul 2, 2005·International Journal of Radiation Oncology, Biology, Physics·Angel I BlancoJoseph O Deasy
Oct 26, 2005·International Journal of Radiation Oncology, Biology, Physics·Jens BuentzelAlexander de Vries

❮ Previous
Next ❯

Citations

Jan 16, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Mary P WalkerBrian Wichman
Dec 30, 2011·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·UNKNOWN Dysphagia Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International SocieFred K L Spijkervet
Sep 18, 2013·Journal of Digital Imaging·Jayashree Kalpathy-CramerClifton D Fuller
Dec 5, 2014·Radiation Oncology·John A Russell, Nadine P Connor
Apr 16, 2008·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Michael Geoffrey PoulsenLee Tripcony
Apr 3, 2007·International Journal of Radiation Oncology, Biology, Physics·Linda S EltingAdam S Garden
Apr 30, 2016·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Zhuo-Shan HuangZhao-Hui Yang
Aug 27, 2013·Ear, Nose, & Throat Journal·Marc I SurkinDeborah A Markiewicz
May 20, 2008·Lancet·Athanassios ArgirisRobert L Ferris

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Review of Anticancer Therapy
David Rosenthal, Angel I Blanco
International Journal of Radiation Oncology, Biology, Physics
G P DelaneyM B Barton
Seminars in Oncology
Jonathan A Ship, Ken Hu
© 2021 Meta ULC. All rights reserved